BNY Mellon Innovators ETF Rating → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free BKIV Stock Alerts $30.85 +0.28 (+0.92%) (As of 05/9/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsSocial MediaStock AnalysisChartHoldingsRatingsSocial Media BNY Mellon Innovators ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BKIV Aggregate RatingModerate Buy2.74Holdings in BKIV have an aggregate rating of Moderate Buy based on 816 analyst ratings issued in the past year covering 49 companies (99.0% of the portfolio).BKIV Aggregate Price Target$37.6422.01% UpsideHigh Prediction$50.34Average Prediction$37.64Low Prediction$24.26Holdings in BKIV have an aggregate price target of $37.64 and a range of $24.26 to $50.34 covering 49 companies (99.0% of the portfolio).BKIV Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by BNY Mellon Innovators ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BKIV Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.94%NVDANVIDIA$887.47-1.8%4 of 5 stars2.95$944.05 6.4%42Analyst Forecast5.00%GOOGAlphabet$171.58+0.2%4 of 5 stars3.00$165.67 -3.4%64.29%CSGPCoStar Group$91.34+1.1%4 of 5 stars2.80$102.46 12.2%15Positive News3.56%NFLXNetflix$612.09+0.4%4 of 5 stars2.60$631.15 3.1%353.38%DXCMDexCom$128.14+0.6%5 of 5 stars2.93$141.67 10.6%14Analyst Downgrade2.89%FRPTFreshpet$118.90-0.3%3 of 5 stars2.79$119.71 0.7%14Analyst Forecast2.73%SNOWSnowflake$155.86-1.2%5 of 5 stars2.64$202.77 30.1%33Analyst Downgrade2.68%SQBlock$73.20+2.9%4 of 5 stars2.76$87.59 19.7%342.67%WHDCactus$51.11+1.1%3 of 5 stars2.14$55.14 7.9%7Insider Selling2.54%TWLOTwilio$59.47+1.5%4 of 5 stars2.32$68.59 15.3%22Analyst Forecast2.54%ALGNAlign Technology$280.39+2.5%5 of 5 stars2.50$353.00 25.9%10Positive News2.44%CELHCelsius$82.07+6.4%2 of 5 stars2.86$84.95 3.5%14Earnings ReportAnalyst ForecastInsider SellingAnalyst Revision2.38%INSPInspire Medical Systems$174.36+6.7%5 of 5 stars2.69$256.53 47.1%16Earnings ReportAnalyst DowngradeAnalyst RevisionHigh Trading Volume2.33%INSMInsmed$26.38+1.5%4 of 5 stars3.00$44.92 70.3%12News CoverageGap Up2.24%ARESAres Management$142.38+2.7%5 of 5 stars2.46$128.08 -10.0%13Analyst Forecast2.19%ASNDAscendis Pharma A/S$133.13-0.6%1 of 5 stars2.88$173.88 30.6%82.11%TTDTrade Desk$88.67+3.1%4 of 5 stars2.77$90.84 2.4%26Analyst ForecastGap Up2.11%TWSTTwist Bioscience$43.20+4.3%2 of 5 stars3.00$42.50 -1.6%6Insider Selling2.07%ISRGIntuitive Surgical$385.45+1.3%5 of 5 stars2.76$396.17 2.8%172.03%SHOPShopify$62.47-0.4%4 of 5 stars2.46$76.86 23.0%35Analyst Forecast1.92%RGENRepligen$164.89-0.4%4 of 5 stars2.89$197.75 19.9%91.89%BMRNBioMarin Pharmaceutical$81.72-0.1%5 of 5 stars2.63$107.50 31.5%191.88%LULULululemon Athletica$352.95+2.1%5 of 5 stars2.67$474.79 34.5%30Analyst Forecast1.82%ABNBAirbnb$147.05-6.9%4 of 5 stars2.15$152.13 3.5%33Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap DownHigh Trading Volume1.78%DVDoubleVerify$18.84+0.3%4 of 5 stars2.80$35.05 86.1%20Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.67%ILMNIllumina$111.35+0.7%5 of 5 stars2.30$164.65 47.9%20Analyst Forecast1.61%SRPTSarepta Therapeutics$132.30-0.2%4 of 5 stars2.79$160.60 21.4%141.59%DKNGDraftKings$44.03+2.8%4 of 5 stars2.82$49.07 11.4%28Analyst Revision1.57%DTDynatrace$46.40+0.7%5 of 5 stars2.82$61.00 31.5%22Upcoming EarningsAnalyst Forecast1.52%MDBMongoDB$354.69+0.4%4 of 5 stars2.72$443.86 25.1%25Gap Down1.41%FWONKFormula One Group$71.15-1.3%3 of 5 stars2.67$82.80 16.4%3Analyst RevisionPositive News1.34%RDDTReddit50.29+0.4%0 of 5 stars2.5616Earnings ReportAnalyst ForecastAnalyst Revision1.33%NTRANatera$95.55-0.1%2 of 5 stars3.00$87.86 -8.1%14Analyst DowngradeHigh Trading Volume1.26%IRTCiRhythm Technologies$99.88+1.1%1 of 5 stars3.00$134.00 34.2%71.25%VITLVital Farms$37.97+26.9%3 of 5 stars2.71$23.00 -39.4%7News CoverageGap UpHigh Trading Volume1.23%ALNYAlnylam Pharmaceuticals$151.37-0.6%5 of 5 stars2.59$216.19 42.8%17Analyst ForecastAnalyst Revision1.16%PACBPacific Biosciences of California$1.72+2.4%4 of 5 stars2.53$7.77 351.9%15News Coverage1.14%KROSKeros Therapeutics$57.60-1.1%3 of 5 stars3.00$86.00 49.3%7Earnings ReportAnalyst ForecastNews CoverageGap Up1.11%TMDXTransMedics Group$128.77+1.2%2 of 5 stars2.88$119.00 -7.6%8Insider Selling0.96%PTONPeloton Interactive$4.46+13.2%4 of 5 stars2.05$5.11 14.6%21Analyst Forecast0.94%CRNXCrinetics Pharmaceuticals$49.42-2.9%3 of 5 stars2.92$57.58 16.5%12Analyst ForecastNews Coverage0.92%PRVAPrivia Health Group$18.03-4.4%5 of 5 stars2.83$26.58 47.4%12News CoverageGap Down0.85%TXG10x Genomics$26.39+4.1%5 of 5 stars2.58$48.50 83.8%120.83%DNLIDenali Therapeutics$18.67-1.2%4 of 5 stars2.89$40.22 115.4%9Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage0.78%CYTKCytokinetics$64.02-1.9%4 of 5 stars2.87$81.60 27.5%15Earnings ReportAnalyst ForecastInsider SellingNews CoverageGap Up0.77%GRMNGarmin$169.30-0.4%5 of 5 stars2.33$153.50 -9.3%6Analyst Downgrade0.59%XENEXenon Pharmaceuticals$42.49-1.0%3 of 5 stars3.00$59.44 39.9%9News Coverage0.38%PRCTPROCEPT BioRobotics$63.00+4.4%1 of 5 stars3.00$61.20 -2.9%70.37%CHWYChewy$16.41+6.3%4 of 5 stars2.65$26.83 63.5%20Analyst Forecast This page (NASDAQ:BKIV) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BNY Mellon Innovators ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
